Select Page

Ebola Fever: Reconciling Ebola Planning With Ebola Risk

Home Forums Infexion Connexion Ebola Fever: Reconciling Ebola Planning With Ebola Risk

 | Click to Receive Email Notifications of Posts
Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #71336
    Marija Juraja
    Participant

    Author:
    Marija Juraja

    Email:
    marija.juraja@HEALTH.SA.GOV.AU

    Organisation:

    State:

    Dear all,

    I would like to know what peoples comments are regarding this article.
    To me it places this disease outbreak in perspective and possibly offers some reassurance re the recommended precautions.
    Again with healthcare workers and ensuring we are protecting them are we placing them more at risk with assuming higher levels of PPE?
    With this higher level could they inadvertently cross contaminate themselves (as hazmat suits etc are not common ward PPE). Happy to hear what people think.

    Annals of internal medicine
    Ideas and Opinions | 21 August 2014
    Ebola Fever: Reconciling Ebola Planning With Ebola Risk in U.S. Hospitals
    Michael Klompas, MD, MPH; Daniel J. Diekema, MD; Neil O. Fishman, MD; and Deborah S. Yokoe, MD
    [+-] Article and Author Information
    Ann Intern Med. Published online 21 August 2014 doi:10.7326/M14-1918

    West Africa is currently in the grip of a terrifying outbreak of Ebola virus disease (Ebola). As of this writing, the outbreak has infected 2127 persons, 1145 (54%) of whom have died. The outbreak currently involves Sierra Leone, Guinea, Liberia, and Nigeria; however, nations around the world are bracing for the possible arrival of travelers, expatriates, and aid workers from West Africa seeking care for documented Ebola or undifferentiated febrile illnesses that might prove to be Ebola.
    Hospitals in the United States are scrambling to develop plans to manage patients with suspected or confirmed Ebola. A major emphasis of planning is specifying measures to protect health care personnel and prevent transmission within health care facilities. However, infection prevention and control teams are struggling to reconcile official guidance from the Centers for Disease Control and Prevention (CDC) with the temptation to maximize precautions that exceed CDC recommendations.
    The CDC recommends placing patients with suspected or confirmed Ebola in a single-patient room and instituting contact and droplet precautions (1). These entail donning a fluid-impermeable gown, gloves, a surgical mask, and either goggles or a face shield. If the patient has “copious” secretions, the CDC also recommends shoe and leg coverings. If an aerosol-generating procedure is planned (such as intubation or bronchoscopy), the CDC recommends wearing an N95 mask and placing the patient in a negative-pressure room. Despite this guidance, many hospitals are planning to place all patients in negative-pressure rooms at all times, to compel all personnel to wear full-body hazardous material (HazMat) suits, and to require N95 masks or powered air-purifying respirators rather than surgical masks at all times.
    Hospitals’ decisions to maximize precautions are understandable given the horrific mortality of this disease and reports of ongoing transmission in African hospitals. Fears among U.S. providers are undoubtedly further spurred by the dramatic footage of ambulance workers in Madrid, Spain, and Atlanta, Georgia, wearing full-body HazMat suits and personal respirators to transport infected patients. However, these excessive measures are unwarranted.
    The CDC’s guidance is evidence-based. There have been more than 20 Ebola outbreaks in the past 40 years (2). Through these outbreaks, public health agencies and researchers have gained considerable experience in the control and prevention of this disease (3-4). Ebola is transmitted by direct contact with patients’ bodily fluids, especially blood. Other risk factors, such as contact with fruit bats or eating fruit that has been nibbled by fruit bats, are not germane to U.S. hospitals.
    Sharing airspace with an infected patient is not a risk factor. Transmission requires direct physical contact and is inefficient. Studies of household contacts of patients with Ebola are informative in this regard. Among 173 household contacts of 27 patients with confirmed Ebola, the transmission rate was only 16% despite none of the standard infection control precautions routinely employed in U.S. hospitals being used (5). Of the 173 householders, 78 reported no physical contact with the infected patient. None became infected. Among those who did have physical contact, the risk for Ebola was highest after contact with patients’ blood. Other investigators have reported similar findings (6).
    Another study evaluated contamination of the care environment (7). Investigators took 54 clinical specimens from 26 laboratory-confirmed Ebola cases. The researchers were able to isolate Ebola virus from 16 of the 54 specimens, including saliva, stool, semen, breast milk, tears, blood, and skin swabs. They then took 33 environmental samples, including swabs from a stethoscope used to examine an infected patient, a bed frame, a bedside chair, a patient’s food bowl, a patient’s spit bowl, the floor, intravenous fluid tubing, and the skin of 3 patient attendants. None were positive. The only extracorporeal specimens that tested positive for Ebola virus were a physician’s blood-stained glove and a bloody intravenous insertion site.
    A case investigation from South Africa further affirms both the effectiveness of standard precautions and the very real risk for transmission through body fluid exposures (8). About 18 years ago, an anesthetics assistant in Johannesburg developed fever, headaches, and mental status changes associated with thrombocytopenia, hepatitis, and progressive renal failure. She was eventually diagnosed with Ebola 12 days after hospitalization. A case investigation was initiated, and her disease was ultimately attributed to care she had provided for a patient 3 days before the onset of her illness. She had helped to insert a central venous catheter in a patient with a febrile, multisystem disease of unknown etiology. The index patient had already recovered and been discharged, but investigators were able to locate him and retroactively confirm Ebola by isolating the virus from a semen specimen. The investigators estimated that more than 300 health care personnel provided care to these 2 patients, including invasive procedures, before Ebola was diagnosed, yet there were no additional transmissions despite the lack of Ebola-specific precautions.
    These investigations affirm the appropriateness of the infection control practices recommended by the CDC. A fluid-impervious gown, gloves, a surgical mask, and a face shield are adequate to protect health care personnel from direct contact with blood or other body fluids during routine care. N95 masks or personal respirators are only necessary during aerosol-generating procedures.
    Exceeding these recommendations may paradoxically increase risk. Introducing new and unfamiliar forms of personal protective equipment could lead to self-contamination during removal of such gear. Requiring HazMat suits and respirators will probably decrease the frequency of provider-patient contacts, inhibit providers’ ability to examine patients, and curtail the use of diagnostic tests. Patients without Ebola may also inadvertently be harmed because Ebola precautions will be required for all suspected cases even though malaria and other infections are more likely in patients from West Africa presenting with fever. Using extra gear inflates patients’ and caregivers’ anxiety levels, increases costs, and wastes valuable resources. More insidiously, requiring precautions that exceed the CDC’s recommendations fans a culture of mistrust and cynicism about our nation’s public health agency.
    As health care professionals, we strive to provide evidence-based care driven by science rather than by the media or mass hysteria. We need to apply these principles to planning for Ebola as well.
    References
    1
    Centers for Disease Control and Prevention. Infection Prevention and Control Recommendations for Hospitalized Patients With Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html on 11 August 2014.

    2
    Centers for Disease Control and Prevention. Outbreaks Chronology: Ebola Hemorrhagic Fever. Atlanta, GA: Centers for Disease Control and Prevention; 2014. Accessed at http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html on 11 August 2014.

    3
    Kerstins B, Matthys F. Interventions to control virus transmission during an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179 Suppl 1:S263-7. [PMID: 9988193]

    4
    Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis. 1999;179 Suppl 1:S259-62. [PMID: 9988192]

    5
    Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidmies Kikwit. J Infect Dis. 1999;179 Suppl 1:S87-91. [PMID: 9988169]

    6
    Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis. 2003;9:1430-7. [PMID: 14718087]

    7
    Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis. 2007;196 Suppl 2:S142-7. [PMID: 17940942]

    8
    Richards GA, Murphy S, Jobson R, Mer M, Zinman C, Taylor R, et al. Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med. 2000;28:240-4. [PMID: 10667531]

    Kind Regards

    Marija Juraja |Clinical Service Coordinator (CICP) -Infection Prevention & Control Unit|
    Division of Acute Medicine
    The Queen Elizabeth Hospital | Central Adelaide Local Health Network
    Level 8 Tower Building | 28 Woodville Road, WOODVILLE SOUTH 5011
    t: +61 8 8222 7588| p: 47757| f: +61 8 8222 6461 | DX: 465432 |e:marija.juraja@health.sa.gov.au

    This email may contain confidential information, which also may be legally privileged. Only the intended recipient(s) may access , use, distribute or copy this email. If this email is received in error, please inform the sender by return email and delete the original. If there are doubts about the validity of this message, please contact the sender by telephone. It is the recipient’s responsibility to check the email and any attached files for viruses.
    [cid:image001.jpg@01CFBD68.DA520310]

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #71342
    Matthew Mason
    Participant

    Author:
    Matthew Mason

    Email:
    mmason1@usc.edu.au

    Organisation:
    University of the Sunshine Coast

    State:
    QLD

    Hi Marija and list members,

    My experience is that the more complicated you make something the more risk there is of mistakes being made. I have some experience in working in full HAZMAT suits. It takes lots of training and continual practice to get right and be comfortable/safe working in. This is not something that can be rolled out quickly. Using PPE to allay fears is not the right way to protect healthcare workers and is likely to do the opposite. It is quite clear that the risk of Ebola is not so much related to how easily it spreads, it is not airborne primarily, but more to the poor health infrastructure (resources, training, workloads and environment) in the areas where we are seeing the outbreak grow. In a health system such as Australia’s, good infection prevention practices at the contact/droplet level in conjunction with appropriate environmental cleaning is what is required.

    Cheers Matt

    Matt Mason RN, CICP, BNSci, M Rural Health, M Advanced Practice (IC)

    Lecturer
    School of Nursing & Midwifery
    Faculty of Science, Health, Education and Engineering
    University of the Sunshine Coast
    University of the Sunshine Coast, Locked Bag 4, Maroochydore DC, Queensland, 4558 Australia.
    CRICOS Provider No: 01595D
    Please consider the environment before printing this email.
    This email is confidential. If received in error, please delete it from your system.

    [Email banner – Racisim. It stops with me. small]

    University of the Sunshine Coast, Locked Bag 4, Maroochydore DC, Queensland, 4558 Australia.
    CRICOS Provider No: 01595D
    Please consider the environment before printing this email.
    This email is confidential. If received in error, please delete it from your system.

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #71346
    Glenys Harrington
    Participant

    Author:
    Glenys Harrington

    Email:
    infexion@ozemail.com.au

    Organisation:
    Infection Control Consultancy (ICC)

    State:

    Hi Marija,

    I agree with the authors perspectives and evidence presented in the article.

    As with SARS the risk of inadvertent contamination increases with the
    introduction of overly complicated or new and unfamiliar forms of personal
    protective equipment particularly when this PPE is being removed. Hence
    the reason during the SARS outbreak it was recommended in may affected
    countries that a second person assist and observe PPE being removed.

    Regards

    Glenys

    Glenys Harrington

    Consultant

    Infection Control Consultancy (ICC)

    PO Box 5202

    Middle Park

    Victoria, 3206

    Australia

    M: +61 404 816 434

    infexion@ozemail.com.au

    ABN 47533508426

    Of Juraja, Marija (Health)
    With Ebola Risk

    Dear all,

    I would like to know what peoples comments are regarding this article.

    To me it places this disease outbreak in perspective and possibly offers
    some reassurance re the recommended precautions.

    Again with healthcare workers and ensuring we are protecting them are we
    placing them more at risk with assuming higher levels of PPE?

    With this higher level could they inadvertently cross contaminate themselves
    (as hazmat suits etc are not common ward PPE). Happy to hear what people
    think.

    Annals of internal medicine

    Ideas and Opinions | 21 August 2014

    Ebola Fever: Reconciling Ebola Planning With Ebola Risk in U.S. Hospitals

    Michael Klompas, MD, MPH; Daniel J. Diekema, MD; Neil O. Fishman, MD; and
    Deborah S. Yokoe, MD

    [ +-]
    Article and Author Information

    Ann Intern Med. Published online 21 August 2014 doi:10.7326/M14-1918

    West Africa is currently in the grip of a terrifying outbreak of Ebola virus
    disease (Ebola). As of this writing, the outbreak has infected 2127 persons,
    1145 (54%) of whom have died. The outbreak currently involves Sierra Leone,
    Guinea, Liberia, and Nigeria; however, nations around the world are bracing
    for the possible arrival of travelers, expatriates, and aid workers from
    West Africa seeking care for documented Ebola or undifferentiated febrile
    illnesses that might prove to be Ebola.

    Hospitals in the United States are scrambling to develop plans to manage
    patients with suspected or confirmed Ebola. A major emphasis of planning is
    specifying measures to protect health care personnel and prevent
    transmission within health care facilities. However, infection prevention
    and control teams are struggling to reconcile official guidance from the
    Centers for Disease Control and Prevention (CDC) with the temptation to
    maximize precautions that exceed CDC recommendations.

    The CDC recommends placing patients with suspected or confirmed Ebola in a
    single-patient room and instituting contact and droplet precautions (
    1).
    These entail donning a fluid-impermeable gown, gloves, a surgical mask, and
    either goggles or a face shield. If the patient has copious secretions,
    the CDC also recommends shoe and leg coverings. If an aerosol-generating
    procedure is planned (such as intubation or bronchoscopy), the CDC
    recommends wearing an N95 mask and placing the patient in a
    negative-pressure room. Despite this guidance, many hospitals are planning
    to place all patients in negative-pressure rooms at all times, to compel all
    personnel to wear full-body hazardous material (HazMat) suits, and to
    require N95 masks or powered air-purifying respirators rather than surgical
    masks at all times.

    Hospitals’ decisions to maximize precautions are understandable given the
    horrific mortality of this disease and reports of ongoing transmission in
    African hospitals. Fears among U.S. providers are undoubtedly further
    spurred by the dramatic footage of ambulance workers in Madrid, Spain, and
    Atlanta, Georgia, wearing full-body HazMat suits and personal respirators to
    transport infected patients. However, these excessive measures are
    unwarranted.

    The CDC’s guidance is evidence-based. There have been more than 20 Ebola
    outbreaks in the past 40 years (
    2).
    Through these outbreaks, public health agencies and researchers have gained
    considerable experience in the control and prevention of this disease (
    3
    4).
    Ebola is transmitted by direct contact with patients’ bodily fluids,
    especially blood. Other risk factors, such as contact with fruit bats or
    eating fruit that has been nibbled by fruit bats, are not germane to U.S.
    hospitals.

    Sharing airspace with an infected patient is not a risk factor. Transmission
    requires direct physical contact and is inefficient. Studies of household
    contacts of patients with Ebola are informative in this regard. Among 173
    household contacts of 27 patients with confirmed Ebola, the transmission
    rate was only 16% despite none of the standard infection control precautions
    routinely employed in U.S. hospitals being used (
    5).
    Of the 173 householders, 78 reported no physical contact with the infected
    patient. None became infected. Among those who did have physical contact,
    the risk for Ebola was highest after contact with patients’ blood. Other
    investigators have reported similar findings (
    6).

    Another study evaluated contamination of the care environment (
    7).
    Investigators took 54 clinical specimens from 26 laboratory-confirmed Ebola
    cases. The researchers were able to isolate Ebola virus from 16 of the 54
    specimens, including saliva, stool, semen, breast milk, tears, blood, and
    skin swabs. They then took 33 environmental samples, including swabs from a
    stethoscope used to examine an infected patient, a bed frame, a bedside
    chair, a patient’s food bowl, a patient’s spit bowl, the floor, intravenous
    fluid tubing, and the skin of 3 patient attendants. None were positive. The
    only extracorporeal specimens that tested positive for Ebola virus were a
    physician’s blood-stained glove and a bloody intravenous insertion site.

    A case investigation from South Africa further affirms both the
    effectiveness of standard precautions and the very real risk for
    transmission through body fluid exposures (
    8).
    About 18 years ago, an anesthetics assistant in Johannesburg developed
    fever, headaches, and mental status changes associated with
    thrombocytopenia, hepatitis, and progressive renal failure. She was
    eventually diagnosed with Ebola 12 days after hospitalization. A case
    investigation was initiated, and her disease was ultimately attributed to
    care she had provided for a patient 3 days before the onset of her illness.
    She had helped to insert a central venous catheter in a patient with a
    febrile, multisystem disease of unknown etiology. The index patient had
    already recovered and been discharged, but investigators were able to locate
    him and retroactively confirm Ebola by isolating the virus from a semen
    specimen. The investigators estimated that more than 300 health care
    personnel provided care to these 2 patients, including invasive procedures,
    before Ebola was diagnosed, yet there were no additional transmissions
    despite the lack of Ebola-specific precautions.

    These investigations affirm the appropriateness of the infection control
    practices recommended by the CDC. A fluid-impervious gown, gloves, a
    surgical mask, and a face shield are adequate to protect health care
    personnel from direct contact with blood or other body fluids during routine
    care. N95 masks or personal respirators are only necessary during
    aerosol-generating procedures.

    Exceeding these recommendations may paradoxically increase risk. Introducing
    new and unfamiliar forms of personal protective equipment could lead to
    self-contamination during removal of such gear. Requiring HazMat suits and
    respirators will probably decrease the frequency of providerpatient
    contacts, inhibit providers’ ability to examine patients, and curtail the
    use of diagnostic tests. Patients without Ebola may also inadvertently be
    harmed because Ebola precautions will be required for all suspected cases
    even though malaria and other infections are more likely in patients from
    West Africa presenting with fever. Using extra gear inflates patients’ and
    caregivers’ anxiety levels, increases costs, and wastes valuable resources.
    More insidiously, requiring precautions that exceed the CDC’s
    recommendations fans a culture of mistrust and cynicism about our nation’s
    public health agency.

    As health care professionals, we strive to provide evidence-based care
    driven by science rather than by the media or mass hysteria. We need to
    apply these principles to planning for Ebola as well.

    References

    1

    Centers for Disease Control and Prevention. Infection Prevention and
    Control Recommendations for Hospitalized Patients With Known or Suspected
    Ebola Hemorrhagic Fever in U.S. Hospitals. Atlanta, GA: Centers for Disease
    Control and Prevention; 2014. Accessed at

    http://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.h
    tml on 11 August 2014.

    2

    Centers for Disease Control and Prevention. Outbreaks Chronology: Ebola
    Hemorrhagic Fever. Atlanta, GA: Centers for Disease Control and Prevention;
    2014. Accessed at

    http://www.cdc.gov/vhf/ebola/resources/outbreak-table.html on 11 August 2014.

    3

    Kerstins B, Matthys F. Interventions to control virus transmission during
    an outbreak of Ebola hemorrhagic fever: experience from Kikwit, Democratic
    Republic of the Congo, 1995. J Infect Dis. 1999;179 Suppl 1:S263-7. [PMID:
    9988193]

    4

    Muyembe-Tamfum JJ, Kipasa M, Kiyungu C, Colebunders R. Ebola outbreak in
    Kikwit, Democratic Republic of the Congo: discovery and control measures. J
    Infect Dis. 1999;179 Suppl 1:S259-62. [PMID: 9988192]

    5

    Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ.
    Transmission of Ebola hemorrhagic fever: a study of risk factors in family
    members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte
    contre les Epidmies Kikwit. J Infect Dis. 1999;179 Suppl 1:S87-91. [PMID:
    9988169]

    6

    Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, et al.
    Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda.
    Emerg Infect Dis. 2003;9:1430-7. [PMID: 14718087]

    7

    Bausch DG, Towner JS, Dowell SF, Kaducu F, Lukwiya M, Sanchez A, et al.
    Assessment of the risk of Ebola virus transmission from bodily fluids and
    fomites. J Infect Dis. 2007;196 Suppl 2:S142-7. [PMID: 17940942]

    8

    Richards GA, Murphy S, Jobson R, Mer M, Zinman C, Taylor R, et al.
    Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic
    aspects. Crit Care Med. 2000;28:240-4. [PMID: 10667531]

    Kind Regards

    Marija Juraja |Clinical Service Coordinator (CICP) -Infection Prevention &
    Control Unit|

    Division of Acute Medicine

    The Queen Elizabeth Hospital | Central Adelaide Local Health Network

    Level 8 Tower Building | 28 Woodville Road, WOODVILLE SOUTH 5011

    t: +61 8 8222 7588| p: 47757| f: +61 8 8222 6461 | DX: 465432
    |e:marija.juraja@health.sa.gov.au

    This email may contain confidential information, which also may be legally
    privileged. Only the intended recipient(s) may access , use, distribute or
    copy this email. If this email is received in error, please inform the
    sender by return email and delete the original. If there are doubts about
    the validity of this message, please contact the sender by telephone. It is
    the recipient’s responsibility to check the email and any attached files for
    viruses.

    60 years+SA health(Small)

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO
    NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is
    discouraged by ACIPC. If you wish to discuss specific reference to products
    or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives
    registration and login required.

    Replies to this message will be directed back to the list. To create a new
    message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 3 posts - 1 through 3 (of 3 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.